Viewing nowCombinationTelostop Tablet 80/10 mg
Telmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.

MFDS item code 201504097 · Approved 2015.06.23 · Insurance code 642905500
Treatment of hypertension and dyslipidemia, reduction of cardiovascular risk, and inhibition of the progression of atherosclerosis
Hello. This medication consists of two components, telmisartan and rosuvastatin, and is used only for patients who are receiving both medications concurrently. Telmisartan is mainly used to treat essential hypertension and to reduce the risk of cardiovascular diseases. In particular, it reduces the risk of myocardial infarction, stroke, and death caused by cardiovascular diseases in high-risk cardiovascular disease patients aged over 55 who cannot use ACE inhibitors. Rosuvastatin lowers cholesterol levels in combination with diet for several types of dyslipidemia related to hypercholesterolemia and delays the progression of atherosclerosis. Additionally, it reduces the risk of stroke and myocardial infarction in certain high-risk groups and aids in percutaneous revascularization. Overall, this medication improves hypertension, dyslipidemia, and associated cardiovascular disease risks.
This drug is for use in adults only. The dose should be individualized for each patient based on the efficacy and tolerability of each component, telmisartan and rosuvastatin. ○ Telmisartan 1. Essential hypertension Adults: The recommended dose of telmisartan is 40 mg orally once daily; 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. This drug provides additional blood pressure-lowering effects when administered concomitantly with thiazide diuretics such as hydrochlorothiazide. When the dose is increased, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after the start of treatment. 2. Reduction of cardiovascular risk Adults: The recommended dose of this drug is 80 mg orally once daily. The risk-reducing effect on cardiovascular morbidity and mortality at doses below 80 mg is unknown. When initiating treatment with this drug to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. 3. Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily. ○ Rosuvastatin calcium 1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients receiving this drug, both before and during treatment, should follow a standard cholesterol-lowering diet and continue it throughout treatment. This drug may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily; if a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response, and may be increased to a maximum of 20 milligrams daily. 2. Elderly patients: No dose adjustment is necessary. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering this drug at 20mg to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score above 9. Do not administer this drug to patients with active liver disease. 5. Race: Because systemic exposure to this drug is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of this drug is contraindicated in some of these patients. Patients taking telmisartan and rosuvastatin concomitantly may switch to this drug (a combination product containing the same amounts of each active ingredient) for convenience.
This medication may cause serious harm to the fetus during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. Individuals with allergies to this medication, pregnant or nursing women, and fertile women not using any contraception should not take this medication. Patients with severely impaired liver function or bile excretion disorders may be at higher risk for side effects due to improper elimination of this medication's components, so they should avoid taking it. Patients with muscle diseases or those who have experienced muscle issues while taking this medication or similar medications should use this medication cautiously and report any symptoms of muscle pain or weakness to their doctors immediately. Patients with severely impaired kidney function or those taking certain immunosuppressants should also avoid taking this medication. Elderly patients, patients with high potassium levels, and patients with mildly impaired liver function should use this medication with caution and require regular blood tests and monitoring. This medication can elevate liver enzyme levels and muscle-related enzyme levels, so regular testing is necessary before and during administration. If muscle pain, weakness, cramping, fatigue, fever, or other symptoms appear during use, medical personnel should be notified immediately. This medication may interact with other antihypertensives or certain lipid-lowering agents, so patients should inform their doctor of any other medications they are taking. Caution is required when driving or operating dangerous machinery, as drowsiness or dizziness may occur. This medication is not recommended for children as safety and efficacy have not been established. In case of overdose, symptoms such as hypotension, arrhythmias, dizziness, and kidney failure may occur, so immediate medical attention is necessary for appropriate treatment. Store this medication out of reach of children and avoid transferring it to other containers.
headache, position-related dizziness, sleep paralysis, elevated blood pressure, decreased blood pressure, hypotension, ALT elevation, painful urination, rhinitis, discomfort in the oropharynx, lung disease, unspecified gastrointestinal disorder, benign gastrointestinal neoplasm, hemorrhoids, skeletal pain, osteoporosis, sensory impairment, movement disorders, atherosclerosis, frequent urination, tinnitus, hearing loss, bad breath, fatty liver, upper respiratory infection, urinary tract infection, sepsis, anemia, thrombocytopenia, eosinophilia, hypersensitivity, anaphylactic reaction, hyperkalemia, hypoglycemia, depression, insomnia, anxiety, syncope, visual disturbances, dizziness, bradycardia, tachycardia, dyspnea, abdominal pain, diarrhea, dyspepsia, abdominal distension, vomiting, abdominal discomfort, dry mouth, liver function abnormalities, liver disorders, increased sweating, itching, rash, erythema, angioedema, drug rash, toxic skin rash, eczema, urticaria, myalgia, low back pain, muscle cramps, arthralgia, limb pain, tendon pain, acute renal failure, chest pain, weakness, influenza-like illness, increased serum creatinine, increased serum uric acid, increased liver enzymes, elevated serum CK, decreased hemoglobin, hypoglycemia, angioedema, hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, multiple neuropathy, memory loss, peripheral neuropathy, cough, dyspnea, diarrhea, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, sexual dysfunction, gynecomastia, interstitial lung disease, fatal and non-fatal liver failure, cognitive impairment, severe muscle weakness, ocular myasthenia, facial spasms, sensory disturbances, paralysis, hyperventilation, pneumonia, flushing, erectile dysfunction, weakness, edema, decreased libido, facial edema, alopecia, conjunctivitis, tinnitus, petechiae, palpitations, fatigue, nausea, inadequate efficacy, arthralgia, numbness, chest discomfort, anorexia, abdominal bloating, syncope, generalized pain, muscle cramps, gout
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container. It is best to maintain storage temperatures between 1 and 30 degrees Celsius.
Bright blue oval film-coated tablet
30 tablets/box [(10 tablets/Alu-Alu)x3], 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhannanghang Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Yuhan Corporation Co., Ltd.
CombinationTelmisartan 40mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 80mg · Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication · Combination
Yuhan Corporation
CombinationTelmisartan 40mg · Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.